Industry
AI will not rescue Ireland's over-budget health IT projects. Pharma-grade governance might.
Public sector health IT projects in Ireland consistently face massive cost overruns. Adopting the strict Computerised System Validation (CSV) and GAMP 5 standards used by the pharmaceutical industry could provide the rigorous governance needed to prevent future digital disasters.
Industry
AI Will Not Rescue Ireland's Over-Budget Health IT Projects. Pharma-Grade Governance Might.
Ireland is entering a 1.5 to 2 billion euro National Electronic Health Record programme with a poor record on large health IT projects. PPARS and the 2021 cyberattack were governance failures, not technology failures, and AI project tools inherit the optimism they are fed. This analysis argues that the discipline the HSE needs already exists in Irish pharma and MedTech under GAMP 5 and the FDA's Computer Software Assurance guidance.
Pharmaceutical
Ireland's Eight-Year Citizenship Rule: A Talent-Retention Problem for Pharma, Biotech and MedTech
Ireland built a life-science powerhouse by being the easiest place in Europe for global talent to land and stay. The proposed move from five to eight years for citizenship changes the terms on which the sector's skilled workforce agreed to come here. This analysis looks at what it means for engineers and scientists on Critical Skills permits, for the companies that depend on them, and what a fairer Bill would look like.
Industry
Ireland's Eight-Year Citizenship Rule: Why It Risks Punishing the Nurses, Carers and Pharma Professionals the Country Cannot Do Without
The Government wants to raise the residency requirement for Irish citizenship from five years to eight, with language and civics tests on top. This analysis looks at who actually carries the weight of that change: the internationally trained nurses, care assistants and pharmaceutical professionals who keep Irish hospitals, nursing homes and manufacturing plants running, and how Ireland would compare with Canada, Australia and the rest of Europe.
Industry
Corporate Compliance and Transparency in Life Sciences 2026: Zurich Dates, Agenda, Tickets and 20% Discount Code
The 9th Annual Corporate Compliance & Transparency in Life Sciences conference runs 17-18 November 2026 in Zurich. Here is everything you need to register: dates, agenda highlights, confirmed speakers, ticket pricing, and an exclusive 20 percent discount code for Priya Life Science readers.
Industry
Jazz Pharmaceuticals Prices Upsized 1.1 Billion Dollar Exchangeable Senior Notes Offering
Jazz Pharmaceuticals has priced an upsized private offering of $1.1 billion in 1.875% exchangeable senior notes due 2032, paired with a concurrent $225 million ordinary share repurchase.
Industry
AI Governance Is Becoming the Next Major Compliance Test for Life Sciences: Why Irish Leaders Must Benchmark in Zurich
As the EU AI Act, updated EFPIA codes, and multi-jurisdictional enforcement reshape life sciences, the 9th Annual Corporate Compliance & Transparency in Life Sciences Conference in Zurich sets the critical 2027 benchmark for Irish biopharma leaders.
Pharmaceutical
Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery
Building on Sreedevi Vijayakumari's analysis of Ireland's infrastructure overruns, this article examines how digital project management practices close the operational delivery gaps behind scope creep, slipped milestones, and portfolio blind spots across public works and life sciences.
Industry
Leveraging Real-Time Data Trackers for Clinical Trials and Regulatory Intelligence in the Life Sciences
A comprehensive guide to the architecture, databases, and clinical utility of the real-time data trackers on Priya Life Science, covering trial registries, HPRA authorizations, and supply chain monitors.
Industry
China Chunlai Education Secures HKEX Waiver for Dublin Business School Acquisition
China Chunlai Education has secured a waiver from the Hong Kong Stock Exchange extending the deadline for its circular regarding the $127.5 million acquisition of Dublin Business School.
Industry
Boston Scientific Prepares to Repatriate 15 Billion Dollars in Dividends from Irish Operation
Boston Scientific has completed a balance sheet reorganisation in Ireland, paving the way to distribute 15 billion dollars in dividends from its Irish subsidiary to global parents.
Industry
22 Irish Companies Recognized in Deloitte EMEA Technology Fast 500 List
Twenty-two high-growth technology companies from the island of Ireland have secured spots on the prestigious Deloitte EMEA Technology Fast 500 list, led by StormHarvester at 24th place.